HIGGS R, LYNN D J, GAINES S, et al. The synthetic form of a novel chicken beta-defensin identified in silico is predominantly active against intestinal pathogens[J]. Immunogenetics, 2005, 57: 90-98.
ELSSNER A, DUNCAN M, GAVRILIN M, et al. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release[J]. The Journal of Immunology, 2004, 172(8):4987-4994.
[10]
YU J, MOOKHERJEE N, WEE K, et al. Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways[J]. The Journal of Immunology, 2007, 179(11):7684-7691.
